Health Guide

Gabapentin for Anxiety: Does It Work?

Gabapentin is increasingly prescribed off-label for anxiety disorders. But is it effective? Here is what the evidence says about gabapentin for generalized anxiety, social anxiety, and panic disorder.

By James Okafor, RPh, MBA
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
Published June 21, 2026
Last reviewed June 15, 2026
2 min read

Is Gabapentin FDA-Approved for Anxiety?

No. Gabapentin is not FDA-approved for any anxiety disorder. Its approved indications are partial seizures, postherpetic neuralgia, and restless legs syndrome (Horizant formulation only). However, gabapentin is widely prescribed off-label for anxiety — it is estimated that anxiety disorders account for a significant portion of off-label gabapentin prescriptions.

How Might Gabapentin Help Anxiety?

Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing the release of excitatory neurotransmitters including glutamate and norepinephrine. Excessive norepinephrine activity is associated with anxiety symptoms (racing heart, hypervigilance, panic). By dampening this excitatory signaling, gabapentin may reduce anxiety symptoms.

Gabapentin also has sedating properties that can reduce the physical symptoms of anxiety (tremors, palpitations, sweating) in the short term.

What Does the Evidence Say?

Anxiety DisorderEvidence QualityKey Findings
Social anxiety disorderModerate (2 RCTs)Pande et al. (1999): gabapentin 900–3,600 mg/day significantly reduced social anxiety vs. placebo; response rate 38% vs. 17%
Generalized anxiety disorder (GAD)Low (limited RCT data)Some positive open-label studies; no large placebo-controlled trials
Panic disorderVery lowCase reports and small studies only; not recommended
Perioperative anxietyModerateGabapentin reduces preoperative anxiety; used in anesthesia protocols
Alcohol withdrawal anxietyModerateGabapentin reduces anxiety and craving during alcohol withdrawal

Typical Dosing for Anxiety (Off-Label)

When gabapentin is used for anxiety, typical doses range from 300–1,800 mg/day in divided doses. Starting doses are usually 100–300 mg at bedtime, titrated up over 1–2 weeks based on response and tolerability.

Side Effects to Expect

The most common side effects of gabapentin are sedation and dizziness, which can be problematic for patients who need to work or drive. Other common side effects include cognitive slowing ("brain fog"), weight gain, and peripheral edema. These side effects are dose-dependent and often improve with time.

Abuse Potential: An Important Consideration

Gabapentin has recognized abuse potential, particularly in patients with a history of substance use disorder. It can produce euphoria and is often misused in combination with opioids. This should be considered before prescribing gabapentin for anxiety in patients with substance use history.

Alternatives to Gabapentin for Anxiety

First-line treatments for anxiety disorders include:

  • SSRIs (sertraline, escitalopram, paroxetine) — First-line for GAD, social anxiety, panic disorder
  • SNRIs (venlafaxine, duloxetine) — First-line for GAD; effective for social anxiety
  • Buspirone — Non-addictive; effective for GAD; takes 2–4 weeks to work
  • Cognitive behavioral therapy (CBT) — Most effective long-term treatment for all anxiety disorders
  • Pregabalin — FDA-approved for GAD in Europe; similar to gabapentin; Schedule V

References

  1. Pande AC, et al. Gabapentin in social phobia: a placebo-controlled study. J Clin Psychopharmacol. 1999;19(4):341-348.
  2. Generoso MB, et al. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis. Int Clin Psychopharmacol. 2017;32(1):49-55.

Save up to 80% on this medication

Use a free RxGo discount card at 67,000+ pharmacies — no sign-up, no insurance needed.

Get Discount
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. Read our full disclaimer.

About the Author

James Okafor, RPh, MBA

Registered Pharmacist & Health Economics Writer

James Okafor is a registered pharmacist with over 12 years of experience in retail and clinical pharmacy settings. He holds an MBA with a focus on healthcare management and specializes in translating complex drug pricing, formulary, and insurance coverage topics into clear, actionable guidance for patients. Before joining RxGuide, James worked as a clinical pharmacist at a regional hospital system and as a pharmacy benefits consultant for a national PBM. His writing focuses on cost transparency, generic alternatives, and helping patients navigate the U.S. prescription drug system.

View full profile on our Editorial Team page →

Get the RxGo app — free prescription discounts on the go

Works at 67,000+ pharmacies · No membership needed

Download